MRI / NSF Resources
S&C Related Contents
Nephrogenic Systemic Fibrosis (NSF)
Nephrogenic Fibrosing Dermopathy (NFD)
Related Websites & Recent Gadolinium Studies
5/23/07 - FDA Press Release
2/07/07 - Study Links Gadolinium treatment to NSF
1/25/07 - MRI Contrast Agent Linked to Rare Disease
1/15/07 - Dialysis to Prevent NSF After Gadolinium Treatment
Prohance (gadoteridol), a gadolinium-based contrast agent which is commonly used to improve the visibility of internal structures when patients undergo an MRI has been linked to a serious, life-threatening disease known as Nephrogenic Systemic Fibrosis (NSF) or Nephrogenic Fibrosing Dermopathy (NFD).
If you or a loved one have had an MRI or MRA, and since developed either NSF or NFD, you should contact us immediately. You may be entitled to compensation and we can help.
On May 23, 2007, the U.S. Food & Drug Administration requested the manufacturers of Prohance (Bracco Diagnostics Inc.) of gadolinium-based contrast agents to add a new boxed warning on the product labeling because of reports linking the agents to the life-threatening skin disorders, Nephrogenic Systemic Fibrosis and Nephrogenic Fibrosing Dermopathy.
“Patients with severe kidney insufficiency who receive gadolinium-based agents are at risk for developing a debilitating, and a potentially fatal disease known as Nephrogenic Systemic Fibrosis (NSF). In addition, patients just before or just after liver transplantation, or those with chronic liver disease, are also at risk for developing NSF if they are experiencing kidney insufficiency of any severity.”
NSF, also known as NFD is a skin condition that is often described as a swelling and tightening of the skin, usually limited to the extremities. The condition may develop over a short period of days or could take weeks to fully develop. NSF can also lead to death.
Severely affected patients may be unable to walk, or fully extend the joints of their arms, hands, legs, and feet. Complaints of muscle weakness are common.
The Products Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Prohance MRI induced NSF lawsuits. We are handling individual litigation nationwide and currently accepting new Prohance MRI scan and Nephrogenic Systemic Fibrosis cases in all 50 states.
Attention Attorneys: We do not publish prior verdict/settlements. If you are an attorney and would like to refer us a case or for us to send you a profile of prior award judgments or average referral fees, please visit the attorney referral section of our website.
Free Confidential Case Evaluation
Toll Free 24 hrs/day (866) 588-0600
Secure 128-bit SSL Encrypted Email Communication - Click Here.
Secure 1024-bit SSL Encrypted Live Chat Communication - Click Here.
= Required Field
| MRI Dye Linked To Potentially Fatal Skin Disease - Health Talk Health Canada is advising consumers of a notice sent to Canadian hospitals advising relevant health care professionals of safety concerns related to contrast agents containing gadolinium. These contrast agents have been linked to a rare and ... |